An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responsesSARS-COV-2 특이 적 T 세포 반응을 결정하기위한 진단 도구로서 플루오 스팟 분석의 평가Research Article Published on 2021-09-302022-09-10 Journal: PLoS ONE [Category] SARS, 진단, 치료법, [키워드] addition Affect aligning Amino acid appear assays blood sample Blood samples calculated cellular Cellular immune response cellular immune responses cellular response Chain Reaction Cohort COVID-19 patients cross-reactive determine diagnostic diagnostic value dual endemic HCoVs evaluated HCoVs HCW healthcare worker Healthcare workers hospitalized COVID-19 patient house human coronavirus human coronaviruses IFN-γ IgG immune response immune responses individuals less nucleocapsid Numerous peptide peptide pool peptide pools polymerase chain polymerase chain reaction post infection reference standard Release repeated Research SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike sensitivity Seroconversion serological serological assays serology seronegative Specificities specificity T cell T cell response [DOI] 10.1371/journal.pone.0258041 PMC 바로가기 [Article Type] Research Article
MHC Variants Associated With Symptomatic Versus Asymptomatic SARS-CoV-2 Infection in Highly Exposed Individuals고도로 노출된 개인의 무증상 SARS-CoV-2 감염 대 무증상 SARS-CoV-2 감염과 관련된 MHC 변이Immunology Published on 2021-09-282022-09-11 Journal: Frontiers in Immunology [Category] SARS, 변종, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age allele analyzed antigen-presentation association Asymptomatic Combination comparable contribute coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 cytotoxic activity develop downregulating DRB1 DRB1*04:01 Epigenetic explained expression Factor Factors followed by Genetic genetic factors Genotype genotypes Haplotype haplotypes histocompatibility complex HLA HLA-A HLA-DRB1 identify immune modulation immune response immunological individual individuals infected individual infected individuals Infection involved low expression major histocompatibility complex MHC MICA MICB modulate natural killer NK cell one individual partner pathway Quantitative remained residue resistance respiratory SARS-CoV-2 seronegative serum severe acute respiratory syndrome Coronavirus susceptibility Symptom symptomatic symptomatic COVID-19 symptomatic infection symptomatic infections uninfected variant variants whole-exome sequencing women [DOI] 10.3389/fimmu.2021.742881 PMC 바로가기 [Article Type] Immunology
Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare WorkersArticle Published on 2021-09-282022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] antibody Antibody Response baseline BNT162b2 clinical effectiveness Clinical studies collected COVID-19 decrease Healthcare professional humoral IgG individuals Month mRNA vaccine NAb NAbs Neutralizing antibodies neutralizing antibody nucleocapsid of BNT162b2 ranged Sample SARS-CoV-2 SARS-CoV-2 vaccination seronegative seropositive seropositive individual seropositive individuals subject tested the spike protein Total total antibody two-dose regimen Vaccination strategies virus were measured worker [DOI] 10.3390/vaccines9101092 PMC 바로가기 [Article Type] Article
Bilateral Acute Optic Perineuritis Associated With COVID-19 in a Patient With Seronegative Myelin Oligodendrocyte Glycoprotein (MOG) AntibodyNeurology Published on 2021-09-242022-10-31 Journal: Cureus [Category] COVID-19, [키워드] ACE-2 acute respiratory syndrome angiotensin-convering-enzyme-2 (ace-2) angiotensin-converting enzyme 2 anterior ischemic optic neuropathy (aion) Autoimmune Bilateral Brain Case report cause Central nervous system CNS Coronavirus-2 COVID-19 COVID-19 infection COVID-19 patient Critically ill Delay Diabetes Mellitus Diagnosis Effect glycoprotein hypertension Infection Inflammation inflammatory disease Injury loss of vision mechanism MOG MRI Myelin myelin oligodendrocyte glycoprotein (mog) Neuroimaging neuromyelitis optica spectrum disorder (nmosd) nonspecific ocular Oligodendrocyte Optic optic nerve sheath optic perineuritis Other Patient Perineuritis radiological finding rare disease receptor seronegative Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Steroids the patient tissues Vasculitis virus were excluded [DOI] 10.7759/cureus.18234 PMC 바로가기 [Article Type] Neurology
Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals무증상 SARS-CoV-2 감염자의 장기간 상승된 염증성 단백질 수치Immunology Published on 2021-09-172022-09-11 Journal: Frontiers in Immunology [Category] SARS, 진단, 치료법, [키워드] activated activated macrophages Alpha antibodies antibody Asymptomatic asymptomatic individual Asymptomatic individuals CD137 CD4 CD69 clinical feature Clinical features clinical monitoring complications controls correlated declined domain Evidence First wave IL18 immune response immune responses individual individuals Infection infections Inflammation inflammation markers inflammatory effect Level life-threatening marker Monocytes N protein no decrease OSM persistence positive individuals Post-infection Protein S-RBD S100A12 SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleocapsid seronegative Seropositivity Serum level serum levels severe disease spike spike receptor-binding domain Spread Support T cell T cell response T cell responses the antibody understanding upregulation Viral viral infection viral neutralization [DOI] 10.3389/fimmu.2021.709759 PMC 바로가기 [Article Type] Immunology
Prospective Cohort Study of the Kinetics of Specific Antibodies to SARS-CoV-2 Infection and to Four SARS-CoV-2 Vaccines Available in Serbia, and Vaccine Effectiveness: A 3-Month Interim ReportArticle Published on 2021-09-172022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] antibody antibody level AstraZeneca BBIBP-CorV BNT-162b2 ChAdOx1-S COVID-19 cut-off dose eight elicited first dose Gam-COVID-Vac Hospitalization individual Infection Interim Kinetics levels of antibody naïve individuals occurred Post-infection Prospective Receptor binding domain recipient recipients remained report required SARS-CoV-2 SARS-COV-2 infection seronegative Sinopharm Specific specific antibodies specific antibody specific IgG antibody spike protein RBD the SARS-CoV-2 vaccination Vaccine vaccine dose vaccine effectiveness Vaccines [DOI] 10.3390/vaccines9091031 PMC 바로가기 [Article Type] Article
Seroprevalence of Immunoglobulin-G Antibody Among Confirm Cases of COVID-19Allergy/Immunology Published on 2021-09-142022-10-31 Journal: Cureus [Category] COVID-19, [키워드] Adults affecting Analysis carried confirmed COVID-19 case COVID COVID-19 COVID-19 case COVID-19 cases COVID-19 infection covid19 cases Decline detected antibody Diagnosis ELISA Factor Gender help highest IgG IgG antibody immune response Immunity immunoglobulin-g antibody increase indicate long-lasting not significant objective positive proportion Research Result Sero-surveillance seronegative Seropositivity Seroprevalence severe acute respiratory syndrome - corona virus-2 statistically time was measured [DOI] 10.7759/cureus.17956 PMC 바로가기 [Article Type] Allergy/Immunology
Infectious SARS-CoV-2 in Exhaled Aerosols and Efficacy of Masks During Early Mild Infection호기 에어로졸의 전염성 SARS-CoV-2와 경증 초기 감염 시 마스크의 효능Major Article Published on 2021-09-142022-09-10 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, 치료기술, [키워드] 95% CI 95% confidence interval aerosol Aerosol generation Aerosols Airborne infection Alpha Alpha variant Anti-spike antibodies binding domain Blood breath collected confounders Control COVID-19 case COVID-19 cases Culture cultured virus enrolled exhaled breath aerosol Face masks Impact increase in Mask Masks not significantly different participant quantified recruited reduced remained Respirator respirators Result Saliva SARS-CoV-2 SARS-CoV-2 epidemiology SARS-CoV-2 RNA SARS-CoV-2 variants sequenced sera seronegative surgical swabs vaccination rate vaccination rates variant variants Viral Viral RNA viruses [DOI] 10.1093/cid/ciab797 PMC 바로가기 [Article Type] Major Article
IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican PopulationArticle Published on 2021-09-082022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] Ad5-nCoV Adenovirus Administered administration adverse effect adverse effects antibodies antibody approved BNT162b2 BNT162b2 vaccine carried deaths detectable Effect Effectiveness ELISA Emergency enzyme-linked immunosorbent first dose Generation IgG IgG antibody measurement mRNA pandemic participant Pfizer/BioNTech Population Prevent protein S S1 IgG Safe SARS-CoV-2 second dose seronegative seropositive participant shown side Side effect subunit vaccination Vaccine Vaccines viral spread [DOI] 10.3390/vaccines9090999 PMC 바로가기 [Article Type] Article
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial아데노바이러스 벡터화 및 mRNA COVID-19 백신(Com-COV)을 사용한 이종 대 상동 프라임-부스트 일정의 안전성 및 면역원성: 단일 맹검, 무작위, 비열등성 시험Clinical Trial Published on 2021-09-042022-09-11 Journal: Lancet (London, England) [Category] Fulltext, MERS, 임상, 진단, [키워드] (ChAdOx1 nCoV-19 Administered age anti-Spike IgG approved assigned AstraZeneca baseline blood test blood tests BNT BNT162b2 boost ChAd ChAdOx1 ChAdOx1 nCoV-19 Cohort Comorbidity comparison Concentration COVID-19 COVID-19 disease COVID-19 vaccine COVID-19 vaccines criteria dose Efficacy eight eligible eligible participant Eligible participants ELISA enrolled evaluate facilitate female participant force geometric mean geometric mean concentration geometric mean ratio GMR greater groups Heterologous heterologous prime-boost heterologous schedule heterologous schedules homologous homologous schedule hospitalisation immune immune responses immunisation immunogenicity immunology inferiority ISRCTN laboratory confirmation limit majority mRNA mRNA vaccine non-inferiority non-inferiority trial occurred Older participant per-protocol population Pfizer-BioNTech primary analysis primary endpoint prime-boost interval prime-boost intervals randomised Randomly reactogenic reactogenicity receive receiving recipient recruited referred to regimen Registered reported Safety safety analyses safety analysis SARS-CoV-2 anti-spike IgG SARS-COV-2 infection Serious Adverse Event seronegative serum single-blind subset Support Task Force the SARS-CoV-2 the vaccine These data Trial vaccination Vaccine Vaccines vectored vaccine was done [DOI] 10.1016/S0140-6736(21)01694-9 PMC 바로가기 [Article Type] Clinical Trial